Careers  |  Sign In  |  Register  |   Twitter

Latest in Business of Medicine

According to Reuters, Esperion Therapeutics‘ ETC-1002 experimental drug has been successful in lowering LDL cholesterol levels in patients who were already taking statins. As a result of the phase-2 study, Esperion stock shares rose 19 percent and were trading at a record high of $91.50. Statins are...
In February of 2015, the New York City Health Business Leaders organization (NYCHBL) held a conference titled “Lean In or Pull Back: Where Will the Healthcare Dollars Flow in 2015?” At this conference, representatives from every sector of the healthcare industry converged to discuss investment...
Prosthetics are not commonly given to children until they finish growing due to their complicated operation and their significant cost. But, The New York Times reports that a volunteer organization called E-nable matches children who need prothetic hands with owners of 3-D printers who are able and willing...